Search Results

ImmunoWELL. VCA IgG Test is for the qualitative detection of IgG antibody to Epstein-Barr Virus viral capsid antigen (VCA) in human serum by ELISA. When the VCA IgG test is used in conjunction with other testing such as the EBV nuclear antigen (EBNA-1), VCA IgM, and EBV early antigen tests and/or heterophile tests, the results can serve as an aid in the diagnosis of infectious mononucleosis (IM).

Microtiter ELISA kit detecting VCA IgG antibodies

Here's an analysis of the provided text to fulfill your request:

1. Table of Acceptance Criteria and Reported Device Performance

The provided text does not explicitly state formal "acceptance criteria" with numerical thresholds for performance metrics. Instead, it describes a comparative study with a predicate device and concludes that the new device performs "essentially the same."

However, we can infer the implicit acceptance criteria based on the study's design: demonstrating substantial equivalence to the predicate device. The performance data presented is a cross-tabulation comparing the new device (ImmunoWELL) with an "Alternate EIA" (which, based on the context of the predicate device, likely refers to the Gull EIA, or a similar method used for comparison).

2. Sample Size Used for the Test Set and Data Provenance

• Test Set Sample Size: The sum of all cases in the provided table is 65 + 8 + 0 + 0 + 7 + 0 + 5 + 1 + 8 = 94 samples.
• Data Provenance: Not explicitly stated. The document does not mention the country of origin or whether the data was retrospective or prospective. It only refers to "sera from suspected patients."

3. Number of Experts Used to Establish Ground Truth and Qualifications of Experts

This information is not provided in the text. The study relies on a comparison against an "Alternate EIA" (likely the predicate device or a similar established method) rather than a defined ground truth established by experts.

4. Adjudication Method for the Test Set

This information is not provided in the text. Given that the comparison is between two EIA tests, there's no indication of an adjudication process in the traditional sense involving human review of discrepancies beyond the test results themselves.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

• No, an MRMC comparative effectiveness study was not conducted. This study describes the performance of an in vitro diagnostic (IVD) device, which is an automated test, not a system designed to assist human readers in image interpretation or similar tasks where MRMC studies are typically performed.

6. Standalone (Algorithm Only) Performance

• Yes, the study describes the standalone performance of the ImmunoWELL VCA IgG Test. Since it is an ELISA kit, its performance is inherently "algorithm only" in the context of an IVD, meaning it operates independently to produce a result. The study compares this standalone performance to another standalone IVD (the predicate device).

7. Type of Ground Truth Used

• The study uses the results of an "Alternate EIA" (likely the predicate device or a highly similar established method) as the reference for comparison. While not explicitly termed "ground truth," this serves as the benchmark against which the new device's performance is measured to establish substantial equivalence. It's a comparative agreement study rather than a direct validation against a clinical "ground truth" like pathology or long-term outcomes. The text mentions the results "can serve as an aid in the diagnosis of infectious mononucleosis (IM)" when used with other tests, indicating that a definitive diagnosis relies on a panel of results, not just this one.

8. Sample Size for the Training Set

• This information is not provided in the text. For IVD devices like this ELISA kit, there isn't typically a "training set" in the machine learning sense. The device's parameters and performance characteristics are established through analytical and clinical validation studies, rather than by training a learnable algorithm.

9. How the Ground Truth for the Training Set Was Established

• As there is no "training set" in the context of an ELISA kit, this question is not applicable. The development of such a kit involves biochemical and immunological design, optimization, and characterization rather than a data-driven training process for an algorithm.

Ask a specific question about this device